About Apta Biosciences
Apta Biosciences is a company based in London (United Kingdom) founded in 2013 by William Addison, Fred Edenius, and Shozo Fujita. It operates as a B2B. Apta Biosciences has raised $4.51 million across 3 funding rounds from investors including European Union, Danish Business Angels and Ranworth Capital. Apta Biosciences operates in a competitive market with competitors including Amyris, Syngenta, AskBio, Ginkgo Bioworks and Antheia, among others.
- Headquarter London, United Kingdom
- Founders William Addison, Fred Edenius, Shozo Fujita
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Apta Biosciences Limited
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$4.51 M (USD)
in 3 rounds
-
Latest Funding Round
$1.13 M (USD), Grant
Dec 01, 2015
-
Investors
European Union
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Apta Biosciences
Apta Biosciences has successfully raised a total of $4.51M across 3 strategic funding rounds. The most recent funding activity was a Grant round of $1.13 million completed in December 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Apta Biosciences
Apta Biosciences has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union, Danish Business Angels and Ranworth Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Angel investor network for businesses
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Apta Biosciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Apta Biosciences
Investment portfolio details for Apta Biosciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Apta Biosciences
Detailed financials for Apta Biosciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Apta Biosciences Comparisons
Peer comparison for Apta Biosciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Apta Biosciences
Apta Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Amyris, Syngenta, AskBio, Ginkgo Bioworks and Antheia, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of renewable products for industrial solutions
|
|
| Locked | Locked | Locked |
Crop protection solutions and hybrid seeds are provided for farming.
|
|
| Locked | Locked | Locked |
Gene and protein therapies are developed for treating various diseases.
|
|
| Locked | Locked | Locked |
Gene editing-based cultured ingredients are provided for agriculture.
|
|
| Locked | Locked | Locked |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| Locked | Locked | Locked |
Synthetic DNA is synthesized via a semiconductor-based platform.
|
Detailed competitors of Apta Biosciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Apta Biosciences
Complete news archive for Apta Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Apta Biosciences
Apta Biosciences was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Apta Biosciences is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Apta Biosciences is a funded company, having raised a total of $4.51M across 3 funding rounds to date.
Apta Biosciences, based in London, focuses on advancing biotech innovations, life sciences, diagnostics and therapeutics, and synthetic biology. Develops innovative synthetic biology technologies for diagnostics and therapeutics. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.
Apta Biosciences has 3 investors. Key investors include European Union, Danish Business Angels, and Ranworth Capital.